A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose (Q34159501)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose |
scientific article |
Statements
1 reference
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose (English)
1 reference
George Wilding
1 reference
Kyle D Holen
1 reference
Chandra P Belani
1 reference
Suresh Ramalingam
1 reference
Jennifer L Volkman
1 reference
Ramesh K Ramanathan
1 reference
Lakshmi S Vasist
1 reference
Carolyn J Bowen
1 reference
Jeffrey P Hodge
1 reference
Mohammed M Dar
1 reference
Peter T C Ho
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference